A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer

Part of paid clinical trials in Palo Alto, California.

Sponsor
Bristol-Myers Squibb
Study ID
NCT06067841
Phase
PHASE1
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
MALE
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • BMS-986460 — DRUG
    Specified dose on specified days.

Study Details

The purpose of this study is to assess the safety, tolerability, and preliminary efficacy of BMS-986460 in men with Metastatic Castration-resistant Prostate Cancer.

Key Dates

Start date
Oct 18, 2023
Status verified
Feb 2026
Primary completion
Aug 24, 2029
Completion
Jul 27, 2031

Study Design

Enrollment
140 participants (estimated)
Allocation
NA
Intervention model
SEQUENTIAL
Primary purpose
TREATMENT

Arms

  • Experimental: Administration of BMS-986460

Primary Outcome Measure

Number of participants with adverse events (AEs) [ Time Frame: Up to 112 weeks ]

Central Contacts

  • BMS Clinical Trials Contact Center www.BMSClinicalTrials.com
    855-907-3286
    [email protected]
  • First line of the email MUST contain NCT # and Site #.

Locations (8)

FacilityCityStateZIPSite coordinators
Stanford Cancer CenterPalo AltoCalifornia94304
Sandhya Srinivas, Site 0004
650-725-2078
Florida Cancer Specialists Sarasota Drug Development UnitSarasotaFlorida34232
Manish Patel, Site 0007
941-377-9993
Dana-Farber Cancer InstituteBostonMassachusetts02215
Atish Choudhury, Site 0003
000-000-0000
Memorial Sloan Kettering Cancer CenterNew YorkNew York10065
Dana Rathkopf, Site 0002
646-422-4379
Duke Cancer InstituteDurhamNorth Carolina27710
Andrew Armstrong, Site 0001
919-668-8797
Local Institution - 0006San AntonioTexas78229-
NEXT OncologySan AntonioTexas78229
David Sommerhalder, Site 0008
210-580-9500
Fred Hutchinson Cancer CenterSeattleWashington98109
Ruben Raychaudhuri, Site 0005
206-618-8002

Find similar trials in Palo Alto, CA

By condition
Prostate cancer
By specialty
OncologyProstate oncologyMen's healthUrology
By research site
Stanford Cancer Center· Palo Alto, CAFlorida Cancer Specialists Sarasota Drug Development Unit· Sarasota, FLDana-Farber Cancer Institute· Boston, MAMemorial Sloan Kettering Cancer Center· New York, NYDuke Cancer Institute· Durham, NCLocal Institution - 0006· San Antonio, TX

Related Studies